Expert introduction
The Kidney Transplantation Department of Zhongshan Hospital affiliated to Fudan University is composed of high-level doctors, pharmacists and researchers. It has rich clinical experience and scientific research results in the field of kidney transplantation. All the clinicians in the department have doctor’s degrees in clinical medicine, and many experts hold positions in the National Society and preside over a number of national, provincial and ministerial research projects. The team of clinicians is experienced in kidney transplantation, perioperative management of kidney transplantation, diagnosis and treatment of postoperative complications, and whole-course management of kidney transplant patients, we are committed to providing scientific, advanced and accurate diagnosis and treatment services for kidney transplant patients.
Zhu Tongyu, professor
MD, chief physician, professor
Director of Shanghai Key Laboratory of Organ Transplantation, director of Shanghai Kidney Transplantation Quality Control Center, and director of Institute of Bacteriophage and research, Fudan University.
Shanghai leading talent, Shanghai Outstanding Academic Leader, Shanghai Health System New 100-person plan, China Hospital Association 2020 Outstanding Hospital President, currently serving as vice president of the Fudan University Shanghai Medical College.
Former chairman of organ transplantation branch of Shanghai Medical Association, member of Organ Transplantation branch of Chinese Medical Association, Vice Chairman of Organ Transplantation branch of Research Hospital Association. He was a member of the organ transplantation branch of the Chinese Medical Association, vice-chairman of the Kidney Transplantation Branch, and vice-chairman of the dialysis and transplantation branch of the Chinese Medical Biomedical Engineering Association.
He has been engaged in clinical and basic research of kidney transplantation for more than 30 years, and has carried out a number of new technologies in the clinical work of kidney transplantation and multi-organ transplantation, we have made a number of progress in the induction of immune tolerance and its basic research in kidney transplantation. Since 2018, we have hosted the first domestic clinical trial of phage therapy for super-resistant bacterial infections and extended it to many domestic medical institutions, institute of Bacteriophage, Fudan University and Shanghai Institute of Bacteriophage and drug resistance were founded. Research on BK virus activation mechanism, prevention and treatment strategies, and pathogen diagnosis and treatment were conducted. The first domestic scientific and educational film on Living Donor Kidney Transplantation was released, he has participated in the formulation of a number of national clinical standards and guidelines for kidney transplantation, and is responsible for presiding over more than 30 scientific research projects such as major national science and technology projects and National Natural Science Foundation projects. He has published more than 280 SCI articles in Nature Medicine, Nature Communications, Emerg Microbes Infect, J Infect, eclinical Medicine, Embo J, Med and other journals, and applied for 11 patents, five of them have been authorised.
He is good at kidney transplantation, including preoperative evaluation, postoperative management and postoperative complications, diagnosis and treatment of multidrug-resistant bacterial infections, and diagnosis and treatment of urinary system tumors.
Rong ruiming, professor
MD, chief physician, professor
He is also the director of Blood Transfusion Department, National Key Laboratory of macromolecular drugs and standardized preparation, Shanghai Key Laboratory of organ transplantation.
He is a member of the standing committee of Transfusion Physicians Branch of Chinese Medical Association, a member of Transplant Physicians Branch, a chairman of Transfusion Committee of Shanghai Medical Association, and a Vice Chairman of Organ Transplant Committee. Member of kidney transplantation branch of China Health Care International Promotion Association, Transplant Technology Branch of China Medical Biotechnology Association, Organ Transplantation Branch of China Research Hospital Association and Precision Medicine Branch of China Hospital Association. He is a biomedical engineering member of the dialysis and Transplantation branch of the Chinese Academy of Medical Sciences, the organ transplantation branch of the cross-straits medical and Health Exchange Association, and the Transplant Immunology Committee of the Chinese Society of Immunology. He is vice-leader of regeneration and engineering group, member of kidney transplantation group and transplant infection group, organ transplantation society, Chinese Medical Association. Review experts of National Natural Science Foundation of China and Shanghai Science and Technology Committee. Member of Shanghai Quality Control Center for kidney transplantation and blood transfusion.
In recent years, he has completed three NSFC general projects, one sub-project of the National Key Research and Development Plan, two NSFC general projects under research, and obtained six patents. In recent years, he has published nearly 50 SCI papers as corresponding author, the total impact factor is more than 200 points, and nearly 40 papers in core journals. At present, he is the editorial board member of Chinese Journal of Organ Transplantation, Chinese Journal of Blood Transfusion, Chinese Journal of Clinical Blood Transfusion and laboratory, and special reviewer of more than 20 SCI journals.
Specializes in kidney transplantation and post-transplant complications of the diagnosis and treatment of urological tumors and other types of disease diagnosis and treatment.
Xu Ming, associate professor
Doctor of Medicine, chief physician, master tutor
Shanghai key laboratory of organ transplantation.
He is also a member of the transplant management committee of the organ transplant physicians branch of the Chinese Medical Doctor Association, a member of the kidney transplant branch of the China Association for International Medical and Health Exchanges, and a member of the organ transplant branch of the cross-straits medical and Health Exchanges Association, member of the Fifth Committee of Organ Transplantation Branch of Shanghai Medical Association, Member of Transplant Immunology Committee of the Council of Shanghai Immunology Association.
He has presided over 1 project of National Natural Science Foundation of China (completed) , 1 project of 11th five-year plan as a major participant, 6 projects of Shanghai Science and Technology Committee Foundation, and 1 project of“Major new drug discovery and development”. He has published more than 20 SCI papers and more than 70 papers in domestic journals.
She specializes in renal transplantation (including preoperative evaluation, postoperative management and management of postoperative complications) and the diagnosis and treatment of urinary system tumors.
Wang Jina, deputy chief physician
Doctor of Medicine, Supervisor of Master students
Deputy Director, Department of Kidney Transplantation, Zhongshan Hospital, Fudan University.
Fudan University and the University of Michigan jointly train medical doctor;
Member, Kidney Transplantation branch of China Medical Association;
Vice-chairman, Youth Committee of Organ Transplantation Branch, Shanghai Medical Associatio
Shanghai Center for quality control of renal transplantation, secretary;
Deputy Director, Fudan University Bacteriophage Institute;
The tenth editorial board of the Chinese Journal of organ transplantation
Vice-chairman of the first youth committee of Kidney Transplantation branch of China Medical Association;
In charge of 2 projects of National Natural Science Foundation, 2 projects of provincial and ministerial level and 1 project of Bureau level
In recent years, he has published more than 10 SCI papers, including Nature Communications, Cellular & Molecular Immunology, Blood, Cell Death & Disease, Transplantation, etc.
He edited an English monograph ABO-incompatible Organ Transplantation, a Chinese monograph pediatric kidney Transplantation, and a popular book about kidney Transplantation.
Editorial guidelines and consensus: Organ Transplantation Society of Chinese Medical Association. Chinese guidelines for the diagnosis and treatment of donor-derived infections in kidney transplantation (2023 edition)[ J ] . Chinese Journal of Organ Transplantation.
Areas of expertise: kidney transplantation, including preoperative evaluation, postoperative management and management of postoperative complications (rejection, infection, etc.) , it includes renal transplantation of ABO-incompatible relatives, renal transplantation of hypersensitized patients, diagnosis and treatment of urinary system tumors, adrenal tumors and prostate diseases.
Yang Cheng, deputy chief physician
Doctor of Medicine, researcher (double engagement) , master tutor
Member of the youth group of the Ninth Committee of the Organ Transplantation Society of the Chinese Medical Association and Member of The Transplantation Foundation Group.
Member, Immunotherapy Engineering Branch, Chinese Biomedical Engineering Society.
Vice Biomedical Engineering of Transplant Immunology Committee, Chinese Society of Immunotherapy Engineering.
Member of transplantation technology branch of China Medical Biological Association.
Member of the Youth Committee of Organ Transplantation Branch of Shanghai Medical Association.
American Transplant Society AST, member of International Transplant Society TTS.
He served as editorial board member of Journal of Translational Medicine (IF: 7.4,2018-2023) , Frontiers in Cell and Developmental Biology (IF: 5.5,2020-2024) , young editorial board member of Chinese Journal of Organ Transplantation (2024-present) , editorial board member of organ transplantation (2017-present) . He served as the CAST reviewer for the International Transplant Congress 2020(TTS) and 2023 Asian transplant conference, and hosted the 2024 International Transplant Congress. He has been a guest editor of SCI. .
In 2018, he was selected as a member of the new excellent youth program of Shanghai Health System. In 2019, he was selected as a member of the Young Star Program of Shanghai Science and Technology Commission, the elite program of China Organ Transplantation Development Foundation, in 2020, he was selected as a top-notch young talent development program of the Organization Department of the Shanghai municipal committee of CPC, and“Excellence 2025” talent program of Fudan University. In 2022, he was selected as an innovative team of high-level local colleges and universities in Shanghai. He presided over one NSFC Youth Foundation project and three general projects, and participated in the 2018 National Key Research and development program of stem cell and translational research as a key project.
Over the past ten years, he has focused on the mechanism and prevention and treatment strategies of kidney transplantation injury and rejection. The research was 2024 a Young Scientist Award from the American Transplant Society (AST) and the International Transplant Society (TTS) between 2012 and 2024. In 2019, he was nominated for the ninth“Top ten medical youth of Fudan University”. In 2020, he was awarded the title of“Young Pioneer” in the fourth national prestigious medical ceremony. In 2021, he was awarded“Excellent young doctor” by Fudan University.
At present, 63 SCI papers have been published as first/corresponding authors (33 corresponding authors) . He edited 6 English books including Kidney Transplantation. Due to the structural modification of the Erythropoietin, it was granted a patent for the invention of CHBP, a polypeptide drug that protects tissues and organs from injury (2015) , and a domestic patent for the non-invasive detection system for the immune status of clinical transplanted kidneys (2019) , two utility model patents (2023) .
She is good at kidney transplantation, including preoperative evaluation, postoperative management and diagnosis and treatment of postoperative complications, and has rich experience in the accurate diagnosis and treatment of complex immune state imbalance after kidney transplantation.
Wang Xuanxuan, deputy chief physician
Doctor of Medicine
Vice Chairman of the Youth Committee of the 11th Committee of the Blood Transfusion Branch of Shanghai Medical Association, member of the second and third committee of the Kidney Transplantation branch of China Association for International Exchange of medical care.
In charge of one NSFC Youth Fund project, awarded 3 utility model patents, published 25 papers as first author or co-author, including 9 Sci. , n Journal of Transplantation. He has written many textbook chapters, including pediatric kidney transplantation, organ transplantation, and special infection surgery. He has also edited and revised the popular science monograph about kidney transplantation.
She specializes in renal transplantation (including preoperative evaluation, postoperative management and management of postoperative complications) and the diagnosis and treatment of urinary system tumors.
Qi guisheng, attending physician
Doctor of Medicine
Long-term engaged in renal transplantation clinical and scientific research work, good at DCD donor kidney transplantation, DCD donor kidney function maintenance. He has presided over one youth project of the National Natural Science Foundation of China and published more than 10 SCI papers as the first author or corresponding author.
She specializes in renal transplantation (including preoperative evaluation, postoperative management and management of postoperative complications) and the diagnosis and treatment of urinary system tumors.
Zhu Dong, attending physician
Doctor of Medicine
From 2011 to 2013, visited the Terasaki Foundation at the University of California, Los Angeles, USA, focusing on highly sensitized kidney transplantation and antibody-mediated rejection Research, with a certificate in Advanced Transplant Immunology Research. He presided over a project of Youth Fund of National Natural Science Foundation of China, and published more than ten papers as the first and corresponding author. He is committed to the clinical, scientific research and medical information work of organ transplantation. His main research directions include the clinical diagnosis and treatment of kidney transplant rejection, immune mechanism research and medical artificial intelligence research. Participated in the design, development and data governance of an AI data exchange system for kidney transplantation in Zhongshan Hospital, we have accumulated some experience in the construction of artificial intelligence fusion-enabled kidney transplantation cohort database, early warning of AI complications, and multidisciplinary diagnosis and treatment. At present, the application of multimodal data in the clinical practice of kidney transplantation is being explored in order to further improve the diagnosis and treatment of kidney transplantation patients through these innovative technologies.
She specializes in renal transplantation (including preoperative evaluation, postoperative management and management of postoperative complications) and the diagnosis and treatment of urinary system tumors.
Zhang Weitao, resident physician
Doctor of Medicine, joint program of Fudan University and Harvard Medical School
In recent years, he has published 9 SCI papers as the first author and co-first author. As a principal, he has presided over one NSFC Youth Science Fund project and one Zhongshan Hospital Project, and participated in many national and municipal projects.
Editor-in-chief, popular science of kidney transplantation, the things about kidney transplantation.
He is good at diagnosis, treatment and postoperative management of renal transplantation.